ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $481,168 | -53.7% | 26,806 | -47.6% | 0.00% | -100.0% |
| Q2 2023 | $1,039,506 | +13.2% | 51,182 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $918,566 | -10.6% | 50,360 | +0.2% | 0.00% | 0.0% |
| Q4 2022 | $1,027,181 | +89.2% | 50,281 | +142.3% | 0.00% | – |
| Q3 2022 | $542,768 | +1.0% | 20,748 | -2.1% | 0.00% | – |
| Q2 2022 | $537,183 | -10.2% | 21,199 | +11.8% | 0.00% | – |
| Q1 2022 | $598,472 | -36.0% | 18,963 | -17.9% | 0.00% | -100.0% |
| Q4 2021 | $935,000 | +14.9% | 23,111 | -1.0% | 0.00% | 0.0% |
| Q3 2021 | $814,000 | +14.5% | 23,354 | -9.8% | 0.00% | 0.0% |
| Q2 2021 | $711,000 | +5.8% | 25,905 | +8.2% | 0.00% | 0.0% |
| Q1 2021 | $672,000 | +2.0% | 23,939 | -5.6% | 0.00% | 0.0% |
| Q4 2020 | $659,000 | +61.1% | 25,369 | +6.4% | 0.00% | – |
| Q3 2020 | $409,000 | -12.6% | 23,852 | +20.4% | 0.00% | – |
| Q2 2020 | $468,000 | +56.5% | 19,812 | -8.1% | 0.00% | – |
| Q1 2020 | $299,000 | +42.4% | 21,567 | +3.5% | 0.00% | – |
| Q4 2019 | $210,000 | -7.1% | 20,835 | -6.0% | 0.00% | – |
| Q3 2019 | $226,000 | +29.1% | 22,157 | +0.6% | 0.00% | – |
| Q2 2019 | $175,000 | +17.4% | 22,027 | +84.4% | 0.00% | – |
| Q1 2019 | $149,000 | – | 11,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |